Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model

Amr Awara,1 Ayman Atiba,2 Duaa Helal,3 Hazem Elbedewy1 1Ophthalmology Department, Tanta University, Tanta, Egypt; 2Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt; 3Pathology Department, Tanta University, Tanta, EgyptC...

Full description

Bibliographic Details
Main Authors: Awara A, Atiba A, Helal D, Elbedewy H
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/effectiveness-of-subconjunctival-cyclosporine-in-treatment-of-acute-al-peer-reviewed-article-OPTH
_version_ 1831583049085616128
author Awara A
Atiba A
Helal D
Elbedewy H
author_facet Awara A
Atiba A
Helal D
Elbedewy H
author_sort Awara A
collection DOAJ
description Amr Awara,1 Ayman Atiba,2 Duaa Helal,3 Hazem Elbedewy1 1Ophthalmology Department, Tanta University, Tanta, Egypt; 2Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt; 3Pathology Department, Tanta University, Tanta, EgyptCorrespondence: Amr AwaraOphthalmology Department, Tanta University, Tanta 31511, EgyptTel +2-01274005384Fax +20403415008Email amrawara@gmail.comBackground: Eye allergy is widely spread worldwide. The treatment includes topical anti-histamines, steroids and non-steroidal drugs. Steroids are the first choice by many ophthalmologists, but unfortunately they may cause serious side effects. Cyclosporine A (CsA) is an immunomodulator drug that can improve eye allergy and reduce the need for steroids; however, topical preparation of CsA is difficult because of the lipophilic nature of the drug.Methods: An experimental study included 16 rats with induced allergy were divided into 2 groups. Group 1: allergic non-treated (6 rats), and Group 2: allergic treated with 0.5 mL subconjunctival CsA 1% (10 rats). Half of each group was sacrificed at 24 hrs and the other half at 1 week. Conjunctival hyperemia and eosinophilic cell count were assessed at each time.Results: Group 2 (CsA treated) showed significantly lower hyperemia score and eosinophilic count at both 24 hrs and 1 week. No ocular complications were noted.Conclusion: Subconjunctival CsA was safe and effective in treating ocular allergy through improving conjunctival hyperemia and reducing eosinophilic cell count with no significant ocular side effects.Keywords: eye allergy, cyclosporine A, eosinophilia, subconjunctival
first_indexed 2024-12-17T20:35:22Z
format Article
id doaj.art-fa6e2818571b477594e2efe420b93a97
institution Directory Open Access Journal
issn 1177-5483
language English
last_indexed 2024-12-17T20:35:22Z
publishDate 2020-02-01
publisher Dove Medical Press
record_format Article
series Clinical Ophthalmology
spelling doaj.art-fa6e2818571b477594e2efe420b93a972022-12-21T21:33:28ZengDove Medical PressClinical Ophthalmology1177-54832020-02-01Volume 1443143551798Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-ModelAwara AAtiba AHelal DElbedewy HAmr Awara,1 Ayman Atiba,2 Duaa Helal,3 Hazem Elbedewy1 1Ophthalmology Department, Tanta University, Tanta, Egypt; 2Department of Surgery, Anesthesiology and Radiology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt; 3Pathology Department, Tanta University, Tanta, EgyptCorrespondence: Amr AwaraOphthalmology Department, Tanta University, Tanta 31511, EgyptTel +2-01274005384Fax +20403415008Email amrawara@gmail.comBackground: Eye allergy is widely spread worldwide. The treatment includes topical anti-histamines, steroids and non-steroidal drugs. Steroids are the first choice by many ophthalmologists, but unfortunately they may cause serious side effects. Cyclosporine A (CsA) is an immunomodulator drug that can improve eye allergy and reduce the need for steroids; however, topical preparation of CsA is difficult because of the lipophilic nature of the drug.Methods: An experimental study included 16 rats with induced allergy were divided into 2 groups. Group 1: allergic non-treated (6 rats), and Group 2: allergic treated with 0.5 mL subconjunctival CsA 1% (10 rats). Half of each group was sacrificed at 24 hrs and the other half at 1 week. Conjunctival hyperemia and eosinophilic cell count were assessed at each time.Results: Group 2 (CsA treated) showed significantly lower hyperemia score and eosinophilic count at both 24 hrs and 1 week. No ocular complications were noted.Conclusion: Subconjunctival CsA was safe and effective in treating ocular allergy through improving conjunctival hyperemia and reducing eosinophilic cell count with no significant ocular side effects.Keywords: eye allergy, cyclosporine A, eosinophilia, subconjunctivalhttps://www.dovepress.com/effectiveness-of-subconjunctival-cyclosporine-in-treatment-of-acute-al-peer-reviewed-article-OPTHeye allergycyclosporine aeosinophiliasubconjunctival.
spellingShingle Awara A
Atiba A
Helal D
Elbedewy H
Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
Clinical Ophthalmology
eye allergy
cyclosporine a
eosinophilia
subconjunctival.
title Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_full Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_fullStr Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_full_unstemmed Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_short Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
title_sort effectiveness of subconjunctival cyclosporine in treatment of acute allergic conjunctivitis in a rat model
topic eye allergy
cyclosporine a
eosinophilia
subconjunctival.
url https://www.dovepress.com/effectiveness-of-subconjunctival-cyclosporine-in-treatment-of-acute-al-peer-reviewed-article-OPTH
work_keys_str_mv AT awaraa effectivenessofsubconjunctivalcyclosporineintreatmentofacuteallergicconjunctivitisinaratmodel
AT atibaa effectivenessofsubconjunctivalcyclosporineintreatmentofacuteallergicconjunctivitisinaratmodel
AT helald effectivenessofsubconjunctivalcyclosporineintreatmentofacuteallergicconjunctivitisinaratmodel
AT elbedewyh effectivenessofsubconjunctivalcyclosporineintreatmentofacuteallergicconjunctivitisinaratmodel